NIFTY
6.40  0.06% 		 11101.65
S&P BSE SENSEX
-24.58  -0.07% 		 37663.33
Aurobindo Pharma Ltd.
NSE : AUROPHARMA BSE : 524804 ISIN code : INE406A01037
on 05-Aug-2020
NSE
-3.45    -0.4%
Rs. 860.65
 
Days Low
Rs. 853.15 		Days High
Rs. 882.5

Open Rs. 870.95
 
52 week Low
Rs. 281.15 		52 week High
Rs.886.9
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
BSE
Rs.860.75
-3.35    -0.39%
on 05-Aug-2020
BSE
-3.35    -0.39%
Rs. 860.75
 
Days Low
Rs. 853.1 		Days High
Rs. 882.65

Open Rs. 869
 
52 week Low
Rs. 288.85 		52 week High
Rs.887.1
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
NSE
Rs.860.65
-3.45    -0.4%
Summary Company Information Fund Holdings
Chart Display Advance Chart
Profit & Loss Balance Sheet Cash Flow Financial Ratios Quarterly Results
 
 
Last Price (Rs.)  860.75 Value  112389293.00
Net Change (Rs.)  -3.35 Best Buy  0.00
Volume  129780 Best Sell  0.00
Prev.Close (Rs.)  864.10 Best Quantity  0
Open (Rs.)  870.95 Sell Quantity  0
High (Rs.)  882.50 52-Week High (Rs.)  886.90
Low (Rs.)  853.15 52-Week Low (Rs.)  281.15
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  504346.66
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital585.90 585.90 585.90 
Share Capital585.90 585.90 585.90 
Share Capital585.90 585.90 585.90 
Share Capital585.90 585.90 585.90 
Share Capital585.90 585.90 585.90 
Currents Investments0.20 0.20 0.20 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 529.00 1269248 103.90 39.53 0.76
Dr. Reddys Lab 4604.70 765451 964.81 26.05 0.54
Divis Lab 2666.25 707806 275.61 53.11 0.60
Cipla 722.55 582598 215.84 30.83 0.55
Biocon 408.45 490140 62.81 111.17 0.00
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Mar 2020Dec 2019Sep 2019
Net Sales36203.2033456.7032216.60
Operating Profit10092.006891.606648.50
PBDT9917.406678.506399.90
Net Profit7250.404190.703981.30
More> 
 
Company News
7/10/2020 12:00:00 AM
Aurobindo Pharma informs about disclosure
6/25/2020 12:00:00 AM
Aurobindo Pharma developing range of products in US, EU markets
6/23/2020 12:00:00 AM
M&M, Maruti Suzuki and Karnataka Bank to see some action today
More>
 
Ratios
   Earnings Per Share (Rs)31.96 
   Book NAV/Share(Rs)222.32 
   PAT Margin (%)14.07 
   Asset Turnover(x)0.71 
   PER(x)12.92 
   Yield(%)0.73 
   EV/Core EBITDA(x)9.02 
   M Cap / Sales1.82 
   Net Sales Growth(%)8.23 
   PAT Growth(%)22.42 
   Total Debt/Equity(x)0.29 
   Current Ratio(x)1.77 
   Quick Ratio(x)1.09 
   Total Debt/Mcap(x)0.15 
More>
 
Privacy Statement  |  Disclaimer  |  Terms of Use   |  Careers  |  Feedback  |   Terms and Conditions  |  Anti Money Laundering Measures  |  Important Policies   |  Dos & Donts   |   BSE  |   NSE  |   SEBI   |   SEBI Scores  |   NCDEX  |   NSDL  |   CDSL  |   RBI  |   AMFI  |   Ministry of Finance  |   Government of India
Copyright © 2012, Khandwala Securities Limited MAPIN UIN100012369, NSE INF2306000030, BSE INB010600030, NCDEX: NCDEX-CO-05-00506, AMFI ARN: 1673, Certificate of Registration as Portfolio Manager INP000000340, Certificate of Registration as Merchant Banking – INM000001899, SEBI Registration No. INB 230600030 (NSE) INB 010600030 (BSE)
For Investor Grievance please mail to: :investorgrievances@kslindia.com
CIN NO. : L67120MH1993PLC070709
Designed, Developed & Content Powered by  ● ● ● Accord Fintech Pvt. Ltd    Best viewed in internet Explorer 7.0 or above